Search filters

List of works by Loretta J Nastoupil

A Prospective Trial of Radiation Therapy Efficacy and Toxicity for Localized Mucosa-associated Lymphoid Tissue (MALT) Lymphoma

scientific article published on 09 December 2020

A phase 1 trial of alisertib and romidepsin for relapsed/refractory aggressive B-cell and T-cell lymphomas

scientific article published on 09 May 2019

A phase I study of romidepsin and ifosfamide, carboplatin, etoposide for the treatment of patients with relapsed or refractory peripheral T-cell lymphoma

scientific article published on 5 April 2018

A phase II study of bortezomib added to rituximab, cyclophosphamide, doxorubicin, vincristine, and prednisone in patients with previously untreated indolent non-Hodgkin's lymphoma

scientific article

A systematic literature review and meta-analysis of radioimmunotherapy consolidation for patients with untreated follicular lymphoma.

scientific article

Additional therapy improves outcomes in completely resected, limited-stage follicular lymphoma

scientific article published on 24 June 2019

An international multicenter retrospective analysis of patients with extranodal marginal zone lymphoma and histologically confirmed central nervous system and dural involvement

scientific article published on 05 December 2019

Antimicrobial Prophylaxis for Adult Patients With Cancer-Related Immunosuppression: ASCO and IDSA Clinical Practice Guideline Update

scientific article published on 04 September 2018

Assessment of Radiation Doses Delivered to Organs at Risk Among Patients With Early-Stage Favorable Hodgkin Lymphoma Treated With Contemporary Radiation Therapy

scientific article published on 01 September 2020

Autologous stem cell transplantation for untreated transformed indolent B-cell lymphoma in first remission: an international, multi-centre propensity-score-matched study

scientific article published on 16 October 2020

Beyond Chemotherapy: Checkpoint Inhibition and Cell-Based Therapy in Non-Hodgkin Lymphoma

scientific article published on 01 May 2018

Breast Implant-Associated Anaplastic Large Cell Lymphoma With Bone Marrow Involvement

scientific article published on 01 June 2018

Bridging therapy prior to axicabtagene ciloleucel for relapsed/refractory large B-cell lymphoma

scientific article published on 01 July 2020

Burden of illness of follicular lymphoma and marginal zone lymphoma

article

Characteristics and management of rash following lenalidomide and rituximab in patients with untreated indolent non-Hodgkin lymphoma

scientific article published on 6 August 2015

Characteristics of anti-CD19 CAR T cell infusion products associated with efficacy and toxicity in patients with large B cell lymphomas

scientific article published on 05 October 2020

Characteristics of patients with myeloproliferative neoplasms with lymphoma, with or without JAK inhibitor therapy

scientific article published on 22 February 2019

Characteristics, management, and outcomes of patients with follicular dendritic cell sarcoma.

scientific article published on 6 April 2017

Chimeric Antigen Receptor T Cell Therapy During the COVID-19 Pandemic

scientific article published on 14 April 2020

Clinical and radiologic correlates of neurotoxicity after axicabtagene ciloleucel in large B-cell lymphoma

scientific article published on 01 August 2020

Clinical efficacy of anakinra to mitigate CAR T-cell therapy-associated toxicity in large B-cell lymphoma

scientific article published on 01 July 2020

Clinicopathological characteristics, outcomes and pattern of mutations in patients with follicular lymphoma who progressed on Bruton tyrosine kinase inhibitors.

scientific article

Coincident primary breast lymphoma and gastrointestinal stromal tumor: case series and molecular mechanisms

scientific article published on 10 December 2018

Comparing the cost-effectiveness of rituximab maintenance and radioimmunotherapy consolidation versus observation following first-line therapy in patients with follicular lymphoma

scientific article

Comparison of the effectiveness of frontline chemoimmunotherapy regimens for follicular lymphoma used in the United States

scientific article published on 05 November 2014

Complete Surgical Excision Is Essential for the Management of Patients With Breast Implant-Associated Anaplastic Large-Cell Lymphoma

scientific article published on 30 November 2015

Considerations in the initial management of follicular lymphoma ⬇️

scientific article published on November 1, 2012

Cost-Effectiveness Analyses, Costs and Resource Use, and Health-Related Quality of Life in Patients with Follicular or Marginal Zone Lymphoma: Systematic Reviews

scientific article published on 21 March 2020

De novo CD5+ diffuse large B-cell lymphoma, NOS: clinical characteristics and outcomes in rituximab era

scientific article published on 18 September 2019

Diffuse large B-cell lymphoma in very elderly patients over 80 years old: Incorporating consolidative radiation therapy into management decisions.

scientific article published on 22 April 2017

Diffuse large B-cell lymphoma: current treatment approaches.

scientific article

Disease characteristics, patterns of care, and survival in very elderly patients with diffuse large B-cell lymphoma

scientific article published on 11 February 2015

Disparities in lymphoma on the basis of race, gender, HIV status, and sexual orientation

scientific article published on 17 November 2017

Disparities in survival by insurance status in follicular lymphoma

scientific article published on 24 July 2018

Disparities in the Early Adoption of Chemoimmunotherapy for Diffuse Large B-cell Lymphoma in the United States ⬇️

scientific article published on July 6, 2012

Disseminated ALK-positive histiocytosis with <i>KIF5B-ALK</i> fusion in an adult

scientific article published on 22 December 2020

Double hit lymphoma: the MD Anderson Cancer Center clinical experience.

scientific article

Doxorubicin-Based Chemotherapy and Radiation Therapy Produces Favorable Outcomes in Limited-Stage Plasmablastic Lymphoma: A Single-Institution Review

scientific article

Early Stage Extranodal Follicular Lymphoma: Characteristics, Management, and Outcomes

scientific article published on 26 February 2019

Efficacy of venetoclax in high risk relapsed mantle cell lymphoma (MCL) - outcomes and mutation profile from venetoclax resistant MCL patients

scientific article published on 02 April 2020

Emerging Treatment Strategies for Primary Breast Extranodal Marginal Zone Lymphoma of Mucosa-associated Lymphoid Tissue

scientific article published on 03 January 2019

Encouraging activity for R-CHOP in advanced stage nodular lymphocyte-predominant Hodgkin lymphoma

scientific article published on 18 May 2017

Evaluating cell-of-origin subtype methods for predicting diffuse large B-cell lymphoma survival: a meta-analysis of gene expression profiling and immunohistochemistry algorithms

scientific article

Experience with HSP90 inhibitor AUY922 in patients with relapsed or refractory non-Hodgkin lymphoma

scientific article published on 27 March 2015

Exploring Risk Factors for Follicular Lymphoma ⬇️

scientific article published on September 18, 2012

Factors influencing outcome in advanced stage, low-grade follicular lymphoma treated at MD Anderson Cancer Center in the rituximab era

scientific article published on 22 January 2016

Favorable outcomes with de-escalated radiation therapy for limited-stage nodular lymphocyte-predominant Hodgkin lymphoma

scientific article published on 01 May 2019

Follicular Lymphoma: Past, Present, and Future

scientific article published on 24 May 2018

Follicular Lymphoma: Recent and Emerging Therapies, Treatment Strategies, and Remaining Unmet Needs

scientific article published on 25 July 2019

Genomic profiles and clinical outcomes of de novo blastoid/pleomorphic MCL are distinct from those of transformed MCL

scientific article published on 01 March 2020

HIV Infection and Survival of Lymphoma Patients in the Era of Highly Active Antiretroviral Therapy

scientific article

Harnessing the immune system through programmed death-1 blockade in the management of Hodgkin lymphoma

scientific article published on 16 February 2017

Hematopoietic recovery and immune reconstitution after axicabtagene ciloleucel in patients with large B-cell lymphoma

scientific article published on 30 July 2020

High ten-year remission rates following rituximab, fludarabine, mitoxantrone and dexamethasone (R-FND) with interferon maintenance in indolent lymphoma: Results of a randomized Study

scientific article published on 24 March 2017

Hitting a Moving Target: Successful Management of Diffuse Large B-cell Lymphoma Involving the Mesentery With Volumetric Image-guided Intensity Modulated Radiation Therapy

scientific article published on 10 September 2018

Ibrutinib for central nervous system lymphoma: the Australasian Lymphoma Alliance/MD Anderson Cancer Center experience

scientific article published on 16 July 2020

Ibrutinib-based therapy for the treatment of marginal zone lymphoma with central nervous system involvement

scientific article published on 10 July 2020

Identifying racial differences in nodular lymphocyte-predominant Hodgkin lymphoma

scientific article

Imaging Surveillance of Limited-stage Classic Hodgkin Lymphoma Patients After PET-CT-documented First Remission

scientific article published on 20 February 2020

Impact of histologic subtypes and treatment modality among patients with primary central nervous system lymphoma: a SEER database analysis.

scientific article published on 22 June 2018

Impact of maintenance rituximab in patients with de novo transformed indolent B cell lymphoma

scientific article published on 06 July 2020

Initial Management Strategies for Follicular Lymphoma ⬇️

scientific article published on October 1, 2012

Initial report of a phase II study with R-FND followed by ibritumomab tiuxetan radioimmunotherapy and rituximab maintenance in patients with untreated high-risk follicular lymphoma

scientific article published on 14 September 2020

Insurance status is related to diffuse large B-cell lymphoma survival

scientific article published on 28 January 2014

Intensive chemotherapy and consolidation with high dose therapy and autologous stem cell transplant in patients with mantle cell lymphoma

scientific article

Lenalidomide plus rituximab (R2 ) in previously untreated marginal zone lymphoma: subgroup analysis and long-term follow-up of an open-label phase 2 trial

scientific article published on 28 March 2019

Lenalidomide, idelalisib, and rituximab are unacceptably toxic in patients with relapsed/refractory indolent lymphoma.

scientific article published on May 2015

Limited stage grade 3 follicular lymphoma patients can experience favorable outcomes with combined modality therapy

scientific article published on 03 April 2019

Long Term Follow-Up of Lenalidomide and Rituximab as Initial Treatment of Follicular Lymphoma

scientific article published on 15 September 2020

Long-Term Remissions of Patients With Follicular Lymphoma Grade 3 Treated With R-CHOP.

scientific article

Maintenance rituximab or observation after frontline treatment with bendamustine-rituximab for follicular lymphoma

scientific article published on 21 December 2018

Management Strategies for Elderly Patients with Diffuse Large B-Cell Lymphoma ⬇️

scientific article published on May 1, 2012

Management of Immune-Related Adverse Events in Patients Treated With Immune Checkpoint Inhibitor Therapy: American Society of Clinical Oncology Clinical Practice Guideline.

scientific article published on 14 February 2018

Management of relapsed chronic lymphocytic leukemia: applying guidelines to practice ⬇️

scientific article published on December 1, 2012

Management strategies and outcomes for very elderly patients with diffuse large B-cell lymphoma.

scientific article published on 28 June 2016

Maternal and Fetal Outcomes After Therapy for Hodgkin or Non-Hodgkin Lymphoma Diagnosed During Pregnancy.

scientific article

Maximizing the effectiveness of oral therapies in lymphoid cancers: research gaps and unmet needs

scientific article published on 04 June 2019

New Challenges in the Management of Diffuse Large B-Cell Lymphoma

scientific article published on January 2012

New insights into the epidemiology of non-Hodgkin lymphoma and implications for therapy

scientific article

Next-generation therapy for follicular lymphoma

scientific article published on 01 October 2018

Novel Agents Beyond Immunomodulatory Agents and Phosphoinositide-3-Kinase for Follicular Lymphoma

scientific article published on 05 May 2020

Novel immunologic approaches in lymphoma: unleashing the brakes on the immune system

scientific article published on July 2015

Novel immunotherapy approaches to follicular lymphoma

scientific article published on 01 November 2018

Novel therapies in mantle cell lymphoma: a pathway to chemotherapy-free strategies

scientific article

Omitting cardiophrenic lymph nodes in the treatment of patients with Hodgkin lymphoma via modified involved-site radiation therapy

scientific article published on 04 April 2018

Outcomes After Reduced-Dose Intensity Modulated Radiation Therapy for Gastric Mucosa-Associated Lymphoid Tissue (MALT) Lymphoma

scientific article published on 12 February 2019

Outcomes and management of patients with mantle cell lymphoma after progression on brexucabtagene autoleucel therapy

scientific article published on 05 November 2020

Outcomes following watchful waiting for stage II-IV follicular lymphoma patients in the modern era.

scientific article published on 5 January 2016

Outcomes of Patients with Large B-cell Lymphoma Progressing after Axicabtagene Ciloleucel

scientific article published on 06 November 2020

Outpatient Management of Fever and Neutropenia in Adults Treated for Malignancy: American Society of Clinical Oncology and Infectious Diseases Society of America Clinical Practice Guideline Update

scientific article published on 20 February 2018

Paclitaxel, topotecan and rituximab: long term outcomes of an effective salvage programme for relapsed or refractory aggressive B-cell non-Hodgkin lymphoma

scientific article published on 08 July 2014

Partial omission of bleomycin for early-stage Hodgkin lymphoma patients treated with combined modality therapy: Does incomplete ABVD lead to inferior outcomes?

scientific article published on 07 February 2020

Patients with classical Hodgkin lymphoma experiencing disease progression after treatment with brentuximab vedotin have poor outcomes.

scientific article

Patterns of failure in advanced stage diffuse large B-cell lymphoma patients after complete response to R-CHOP immunochemotherapy and the emerging role of consolidative radiation therapy

scientific article published on 26 March 2013

Patterns of use and survival outcomes of positron emission tomography for initial staging in elderly follicular lymphoma patients.

scientific article

Peripheral T-cell lymphomas in a large US multicenter cohort: prognostication in the modern era including impact of frontline therapy

scientific article published on 5 September 2014

Phase II Study of Bortezomib in Combination with Cyclophosphamide and Rituximab for Relapsed or Refractory Mantle Cell Lymphoma

scientific article

Phase-I and randomized phase-II trial of panobinostat in combination with ICE (ifosfamide, carboplatin, etoposide) in relapsed or refractory classical Hodgkin lymphoma.

scientific article published on 9 August 2017

Point: Can Chemotherapy Be Eliminated in the Treatment of Follicular Lymphoma?

scientific article published on 01 August 2018

Population-specific prognostic models are needed to stratify outcomes for African-Americans with diffuse large B-cell lymphoma

scientific article published on 28 September 2015

Positron emission tomography-computed tomography predictors of progression after DA-R-EPOCH for PMBCL

scientific article published on 01 June 2018

Pre-treatment maximum standardized uptake value predicts outcome after frontline therapy in patients with advanced stage follicular lymphoma

scientific article published on 10 October 2019

Predictors of Hypothyroidism in Hodgkin Lymphoma Survivors After Intensity Modulated Versus 3-Dimensional Radiation Therapy

scientific article published on 14 March 2018

Predictors of radiation pneumonitis in patients receiving intensity modulated radiation therapy for Hodgkin and non-Hodgkin lymphoma

scientific article published on May 2015

Premature closure of a phase II study of bendamustine, mitoxantrone and rituximab for patients with untreated high-risk follicular lymphoma due to severe haematological and infectious toxicity

scientific article published on 18 December 2015

Pretreatment SUVmax may influence the clinical benefit of BR over R-CHOP in patients with previously untreated FL

scientific article published on 23 January 2020

Primary breast diffuse large B-cell lymphoma: treatment strategies and patterns of failure<sup/>

scientific article published on 26 April 2018

Prognostic significance of baseline peripheral absolute neutrophil, monocyte and serum β2-microglobulin level in patients with diffuse large b-cell lymphoma: a new prognostic model.

scientific article published on 22 July 2016

Racial Differences in the Presentation and Outcomes of Chronic Lymphocytic Leukemia and Variants in the United States ⬇️

scientific article published on September 1, 2011

Radiation Therapy as an Effective Salvage Strategy for Secondary CNS Lymphoma.

scientific article published on 6 January 2018

Radiation therapy for salivary gland MALT lymphoma: ultra-low dose treatment achieves encouraging early outcomes and spares salivary function

scientific article published on 02 August 2019

Radiation therapy improves survival in patients with testicular diffuse large B-cell lymphoma.

scientific article published on 9 May 2017

Recent insights into large granular lymphocytic leukemia

scientific article published on 01 July 2018

Relations Between Residential Proximity to EPA-Designated Toxic Release Sites and Diffuse Large B-Cell Lymphoma Incidence

scientific article

Residence proximity to benzene release sites is associated with increased incidence of non-Hodgkin lymphoma.

scientific article

Response-adapted radiation therapy for newly diagnosed primary diffuse large B-cell lymphoma of the CNS treated with methotrexate-based systemic therapy

scientific article published on 12 July 2018

Role of the tumor microenvironment in mature B-cell lymphoid malignancies

scientific article

Routine use of maintenance therapy in follicular lymphoma: the strategy is effective, raising the question, 'what is the most important measure of success in the current era?'.

scientific article published in September 2014

Safety and activity of lenalidomide and rituximab in untreated indolent lymphoma: an open-label, phase 2 trial

scientific article

Safety of CAR T-cell therapy in patients with B-cell lymphoma and chronic hepatitis B or C virus infection

scientific article published on 17 May 2019

Selective Inhibition of HDAC3 Targets Synthetic Vulnerabilities and Activates Immune Surveillance in Lymphoma

scientific article published on 08 January 2020

Sequencing of therapies in relapsed follicular lymphoma

scientific article published on 01 November 2018

Single-institution experience in the treatment of primary mediastinal B cell lymphoma treated with immunochemotherapy in the setting of response assessment by 18fluorodeoxyglucose positron emission tomography

scientific article published on May 2015

Socioeconomic disparities in lymphoma

scientific article

Stage I Non-Hodgkin Lymphoma: difference in survival outcome by primary extranodal site of involvement

scientific article published on 05 July 2018

Stage I non-Hodgkin lymphoma: no plateau in disease-specific survival ?

scientific article published on 08 January 2019

Standard-of-Care Axicabtagene Ciloleucel for Relapsed or Refractory Large B-Cell Lymphoma: Results From the US Lymphoma CAR T Consortium

scientific article published on 13 May 2020

Surveillance imaging in mantle cell lymphoma in first remission lacks clinical utility.

scientific article published on 10 August 2017

The combination of ibrutinib and rituximab demonstrates activity in first-line follicular lymphoma

scientific article published on 16 March 2020

The need to assess financial adverse events

scientific article published on 12 June 2018

The risk of central nervous system relapses in patients with peripheral T-cell lymphoma

scientific article published on 14 March 2018

The role of chemotherapy in managing chronic lymphocytic leukemia: optimizing combinations with targeted therapy

scientific article published on 07 August 2013

The survival outcome of patients with relapsed/refractory peripheral T-cell lymphoma-not otherwise specified and angioimmunoblastic T-cell lymphoma.

scientific article

The use and effectiveness of rituximab maintenance in patients with follicular lymphoma diagnosed between 2004 and 2007 in the United States.

scientific article

To Each Its Own: Linking the Biology and Epidemiology of NHL Subtypes

scientific article published on 24 June 2015

Tolerability and activity of ublituximab, umbralisib, and ibrutinib in patients with chronic lymphocytic leukaemia and non-Hodgkin lymphoma: a phase 1 dose escalation and expansion trial

scientific article published on 01 February 2019

Treatment Strategies for Patients with Diffuse Large B-Cell Lymphoma: Past, Present, and Future

scientific article published on April 2012

Ublituximab and umbralisib in relapsed/refractory B-cell non-Hodgkin lymphoma and chronic lymphocytic leukemia

scientific article published on 01 November 2019

Ultra-low-dose radiotherapy for definitive management of ocular adnexal B-cell lymphoma

scientific article published on 3 April 2017

Ultra-low-dose radiotherapy for definitive management of ocular adnexal B-cell lymphoma

scientific article published on 21 February 2018

Ultra-low-dose radiotherapy for definitive management of ocular adnexal B-cell lymphoma

scientific article published on 19 March 2019

Unmet needs in the first-line treatment of follicular lymphoma

scientific article published on 18 April 2017

Using primary site as a predictor of survival in mantle cell lymphoma ⬇️

scientific article published on January 22, 2013

Venetoclax, bendamustine, and rituximab in patients with relapsed or refractory NHL: a phase Ib dose-finding study

scholarly article by S de Vos et al published 1 September 2018 in Annals of Oncology

Where to start? Upfront therapy for follicular lymphoma in 2018

scientific article published on 01 November 2018

Paulina is supported by:

About Paulina

Help